| Autor: |
Tassi, Renato, Baldazzi, Valentina, Lapini, Alberto, Carini, Marco, Mazzanti, Roberto |
| Zdroj: |
Clinical Genitourinary Cancer; 20240101, Issue: Preprints |
| Abstrakt: |
Thyroid function impairment is commonly observed in patients with metastatic renal cell carcinoma receiving sunitinib. Effects of sunitinib on serum lipids are not described but could depend on a hypothyroid state. We evaluated serum lipids in 39 consecutive patients taking sunitinib. A hyperlipidemic state was observed and was related to drug toxicity. Careful monitoring of serum lipids during sunitinib administration is recommended. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
Full Text from ScienceDirect